ARUP Laboratories to Present Mini-Lecture Series at American Association for Clinical Chemistry (AACC) 2011 Annual Meeting

ARUP’s CEO, Dr. Edward Ashwood, will headline a series of lectures discussing relevant topics to the changing tide of clinical laboratory medicine and healthcare in the United States

SALT LAKE CITY--(BUSINESS WIRE)-- In an effort to share its expertise and leadership with the clinical laboratory industry, ARUP Laboratories will present a mini-lecture series in its booth (#1838) at the American Association for Clinical Chemistry (AACC) 2011 Annual Meeting & Clinical Lab Expo, taking place July 24 – 28 in Atlanta, Ga.

“The changes looming for healthcare and laboratory medicine are as dramatic as I can remember,” said Edward Ashwood, MD, president and CEO of ARUP Laboratories. “For this year’s show, we are hosting a mini-lecture series in an intimate setting. The topics were chosen to allow us to share our thoughts and perspectives on these changes.”

Lectures will last roughly 20 minutes and presenters will be available afterward for a question and answer session. Seating is limited and lecture attendees will be entered in a drawing for an iPad® 2 to be given away after each lecture (winners must be present during the lecture and drawing to win).

Lecture times and topics are as follows:

Tuesday, July 26, 2011

  • 10:30 AM, Edward Ashwood, MD, President and CEO of ARUP Laboratories
    Five Macro Challenges Facing the Laboratory Industry
  • 2:00 PM, Brian Jackson, MD, Medical Director, Medical Informatics at ARUP Laboratories
    Stopping Laboratory Leakage

Wednesday, July 27, 2011

  • 10:30 AM, Gwen McMillin, PhD, Medical Director, Toxicology and Trace Elements Laboratories, Co-Medical Director, Pharmacogenetics at ARUP Laboratories
    Pain Management Update: Evaluating Adherence to Prescription Opioids with Urine Drug Testing
  • 2:00 PM, Elaine Lyon, PhD, Medical Director, Genetics Division, Co-Medical Director, Pharmacogenetics at ARUP Laboratories
    Interpreting Genetic Variation: Examples from X-linked Intellectual Disability

In addition to the mini-lecture series, ARUP medical directors, researchers and staff will present more than 20 posters and educational sessions on a variety of topics, ranging from laboratory testing and science to laboratory administration.

Additional information about ARUP Laboratories’ mini-lecture series at the AACC Clinical Lab Expo is available at http://aruplab.com/events/trade-shows/2011/AACC/index.php.

About ARUP Laboratories

Founded in 1984, ARUP Laboratories is a leading national reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. ARUP offers more than 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation’s top university teaching hospitals and children’s hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®.



CONTACT:

ARUP Laboratories
Kristofer Beldin, 801-583-2787, ext. 2451
cell: 801-946-2987
[email protected]
Vesna Ilic, 801-583-2787, ext. 2861
or 801-888-4563
[email protected]
Cyndee Holden, 801-583-2787, ext. 3318
cell: 801-386-6637
[email protected]

KEYWORDS:   United States  North America  Georgia  Utah

INDUSTRY KEYWORDS:   Health  Biotechnology  Genetics  Hospitals  Infectious Diseases  Oncology  Research  Nursing  Science  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.